Total Voting Rights - correction

Summary by AI ^BETAClose X

BP PLC has issued a revised announcement clarifying its issued share capital as of June 30, 2026, correcting a previous omission of treasury shares. The company now reports 15,702,899,365 ordinary shares excluding treasury shares, with 783,413,629 ordinary shares held in treasury, which do not carry voting rights or impact dividend payments. The total number of voting rights for BP PLC shareholders is 15,707,981,865, a figure shareholders can use for FCA Disclosure Guidance and Transparency Rules notifications.

Disclaimer*

BP PLC

06 July 2026

This announcement replaces the announcement released at 12.02pm on 1 July 2026 under RNS No: 6392K.

The revised announcement shows the correct Issued Share Capital excluding treasury shares (15,702,899,365) figure. The treasury shares figure was included in the original announcement. All other figures remain the same.

BP p.l.c.

Total voting rights and share capital

As at 30 June 2026, the issued share capital of BP p.l.c. comprised 15,702,899,365 ordinary shares (excluding treasury shares) par value US$0.25 per share, each with one vote; and 12,706,252 preference shares par value £1 per share with two votes for every £5 in nominal capital held.

The number of ordinary shares held in treasury by BP p.l.c. is 783,413,629. These treasury shares are not taken into consideration in relation to the payment of dividends and voting at shareholder meetings.

The total number of voting rights in BP p.l.c. is 15,707,981,865. This information may be used by shareholders for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, BP p.l.c. under the FCA's Disclosure Guidance and Transparency Rules ("DGTRs").

This announcement is made in accordance with the requirements of DGTR 5.6.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END